🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchBimagrumab + semaglutide — myostatin inhibitor combo for body recomp Page 4

Bimagrumab + semaglutide — myostatin inhibitor combo for body recomp

MikeFit_NJ Thu, May 14, 2026 at 9:31 AM 22 replies 751 viewsPage 4 of 5
sarah_nash92
Member
712
3,123
Jun 2024
Nashville, TN
May 16, 2026 at 12:57 AM#16
PharmD_Rodriguez said:
MikeFit_NJ said: ...but the FDA says semaglutide...

This is my experience too, for whatever a second data point is worth. Nothing to add that would improve it.

44 19NauseaFreeNow, SteveThurs, B12Beth and 41 others
Reply Quote Save Share Report
emma_london
Member
312
1,456
Oct 2024
London, UK
May 16, 2026 at 6:04 AM#17
Dr.PeteFamMed said:
One habit that pays for itself: post the method alongside the number.

I read this differently from Dr.PeteFamMed, on substance rather than tone. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

43 18mike.trainer_LA, sarah_nash92, FitDadDave and 40 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
May 16, 2026 at 11:11 AM#18
Dr.PeteFamMed said:
One habit that pays for itself: post the method alongside the number.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

Last edited: May 16, 2026 at 4:11 PM
42 17mona_PHX, andrew_nyc, Dr.EndoEP and 39 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
May 16, 2026 at 4:18 PM#19
Dr.PeteFamMed said:
One habit that pays for itself: post the method alongside the number.

This answered a question I did not know how to ask. Adding it to my notes with a link back to this thread.

41 16Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 38 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 16, 2026 at 9:25 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Thread quality here is what the rules are for. Keep it up.

19 19PurityPaulOR, MaxMetOK, MounjBrad and 16 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register